Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29)
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-22
DOI
10.1007/s11010-021-04158-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Curcumin induced apoptosis is mediated through oxidative stress in mutated p53 and wild type p53 colon adenocarcinoma cell lines
- (2020) Sruthi Sritharan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- The impact of cancer type, treatment, and distress on health-related quality of life: cross-sectional findings from a study of Australian cancer patients
- (2019) David J. T. Marco et al. SUPPORTIVE CARE IN CANCER
- CB2 receptor agonist JWH133 activates AMPK to inhibit growth of C6 glioma cells
- (2019) Feng Wang et al. Open Life Sciences
- Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
- (2018) Mohammed I. Khan et al. BMC CANCER
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer
- (2018) Lihi Bar-Lev Schleider et al. European Journal of Internal Medicine
- Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells
- (2018) Antonella Capozzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The CB2 receptor and its role as a regulator of inflammation
- (2016) Caroline Turcotte et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
- (2016) Farideh A. Javid et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
- (2016) A. I. Fraguas-Sánchez et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat
- (2016) R. Abalo et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
- (2016) Maria Pyszniak et al. OncoTargets and Therapy
- CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
- (2016) Esther Martínez-Martínez et al. Oncotarget
- Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
- (2016) Daniel A. Ladin et al. Frontiers in Pharmacology
- A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer
- (2015) Bengt Gustavsson et al. Clinical Colorectal Cancer
- Endocannabinoid and ceramide levels are altered in patients with colorectal cancer
- (2015) LING CHEN et al. ONCOLOGY REPORTS
- The Molecular Pathogenesis of Colorectal Cancer and Its Potential Application to Colorectal Cancer Screening
- (2014) William M. Grady et al. DIGESTIVE DISEASES AND SCIENCES
- Activation of Cannabinoid Type 2 Receptor by JWH133 Protects Heart Against Ischemia/Reperfusion-Induced Apoptosis
- (2013) Qian Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
- (2009) Sadiye Amcaoglu Rieder et al. IMMUNOBIOLOGY
- A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist
- (2009) N. T. Snider et al. MOLECULAR PHARMACOLOGY
- Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
- (2008) Marnie Duncan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways
- (2008) M G Belvisi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor -Mediated Ceramide De novo Synthesis in Colon Cancer Cells
- (2008) F. Cianchi et al. CLINICAL CANCER RESEARCH
- Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation
- (2007) K L Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1
- (2007) Robert Ramer et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now